For Urologists, healing is urgent. Clarix® is your answer.

Clarix for Urology

Clarix 1K is a cryopreserved ultra-thick human birth tissue allograft used as an adjunct for surgical applications to create a protective environment for healing.

When adult healing fails you, Clarix can help by managing inflammation, managing adhesion formation, and facilitating soft tissue healing.

Start your journey with Clarix by filling out the form below:

To learn more about Clarix, fill out the details below:
By clicking the button below, I agree to receive marketing communications from BioTissue. I am aware that I can unsubscribe at any time.
This field is for validation purposes and should be left unchanged.

Clarix is an ultra-thick allograft providing ease of use in robotic procedures.

Allograft placement over Neurovascular Bundles (NVBs) after prostate resection.

Allograft wrap after Ileal-Ureteral anastomosis repair.

Allograft placement for complex urinary fistula repair.

Introducing allograft into the surgical site using a single port robot.

Watch the video below of Dr. Mutahar Ahmed (Hackensack Meridian Health, Hackensack, NJ) sharing how human birth tissue has transformed his surgical outcomes.

In this video, Dr. Mutahar Ahmed (Hackensack Meridian Health, NJ) discusses the use of a BioTissue’s birth tissue allograft to prevent healing complications after stricture repair in a patient who underwent radiation therapy for prostate cancer.

Hear Dr. Mutahar Ahmed  explain why he chooses BioTissue birth tissue allografts as an adjunct in Oncological and Reconstructive Urology procedures.

The Proof is in the Evidence

Improved clinical outcomes are supported by our clinical evidence in Oncological and Reconstructive Urology applications:

  • 83% of patients achieved continence at 3-months when Clarix was used as an adjunct in RARP.1
  • 75% of patients achieved potency at 6-months when Clarix was used as an adjunct in RARP.2
  • A patient with a distal ureteral stricture underwent ureterolysis with adjunctive Clarix 1K without complication and resolution of hydroureteronephrosis at 6-months post-surgery.3

At the time of surgery, give that one chance its best chance with Clarix.

To learn more about Clarix, fill out the details below:
By clicking the button below, I agree to receive marketing communications from BioTissue. I am aware that I can unsubscribe at any time.
This field is for validation purposes and should be left unchanged.
References
Ahmed M, Esposito M, et al. J Robot Surg. 2020 Apr;14(2):283-289. doi: 10.1007/s11701-019-00972-9).
Stites, J., et al., Initial Experience with a Bioregenerative Matrix on Erectile Function Following Nerve-Sparing Robot-Assisted Laparoscopic Radical Prostatectomy, in World Congress of Endourology. 2018: Paris, France.
Cheng N, et al. J Endourol Case Rep. 2020 Dec 29;6(4):431-434. doi: 10.1089/cren.2020.0185.